Trial Profile
A cohort study to evaluate the diffusion weighted imaging and MRI protocol for the diagnosis and assessment of disease severity in ankylosing spondylitis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Feb 2016
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Ankylosing spondylitis
- Focus Pharmacodynamics; Therapeutic Use
- 11 Feb 2016 New trial record